Predicting 7-year mortality for use with evidence-based guidelines for Prostate-Specific Antigen (PSA) testing: findings from a large prospective study of 123 697 Australian men.
Joshy, Grace
Predicting 7-year mortality for use with evidence-based guidelines for Prostate-Specific Antigen (PSA) testing: findings from a large prospective study of 123 697 Australian men. [electronic resource] - BMJ open 12 2018 - e022613 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2044-6055
10.1136/bmjopen-2018-022613 doi
Aged
Aged, 80 and over
Cause of Death
Cohort Studies
Disability Evaluation
Early Detection of Cancer
Early Diagnosis
Early Medical Intervention
Evidence-Based Medicine
Guideline Adherence
Humans
Kallikreins--blood
Male
Middle Aged
New South Wales
Predictive Value of Tests
Prospective Studies
Prostate-Specific Antigen--blood
Prostatic Neoplasms--mortality
Risk
Survival Analysis
Predicting 7-year mortality for use with evidence-based guidelines for Prostate-Specific Antigen (PSA) testing: findings from a large prospective study of 123 697 Australian men. [electronic resource] - BMJ open 12 2018 - e022613 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2044-6055
10.1136/bmjopen-2018-022613 doi
Aged
Aged, 80 and over
Cause of Death
Cohort Studies
Disability Evaluation
Early Detection of Cancer
Early Diagnosis
Early Medical Intervention
Evidence-Based Medicine
Guideline Adherence
Humans
Kallikreins--blood
Male
Middle Aged
New South Wales
Predictive Value of Tests
Prospective Studies
Prostate-Specific Antigen--blood
Prostatic Neoplasms--mortality
Risk
Survival Analysis